Alnylam Pharmaceuticals, INC. (ALNY) — SC 13G/A Filings

All SC 13G/A filings from Alnylam Pharmaceuticals, INC.. Browse 10 SC 13G/A reports with AI-powered summaries and risk analysis.

SC 13G/A Filings (10)

SC 13G/A Filing — Nov 12, 2024
SC 13G/A Filing — Nov 8, 2024
SC 13G/A Filing — Aug 12, 2024
SC 13G/A Filing — Jul 5, 2024
SC 13G/A Filing — Feb 13, 2024
Capital World Investors Cuts ALNY Stake to 13.5% — Feb 9, 2024 Risk: medium
Capital World Investors, a major institutional investor, filed an amended SC 13G/A on February 9, 2024, disclosing a decrease in its beneficial ownership of Aln
FMR LLC & Abigail Johnson Disclose 8.239% Stake in Alnylam Pharma — Feb 9, 2024 Risk: low
FMR LLC, a major investment firm, and its principal owner, Abigail P. Johnson, have updated their holdings in Alnylam Pharmaceuticals Inc. As of December 31, 20
Wellington Management Amends Alnylam Pharma Stake (12th Update) — Feb 9, 2024 Risk: low
Wellington Management Group LLP, a major investment firm, filed an amendment (SC 13G/A) on February 9, 2024, updating its ownership in Alnylam Pharmaceuticals,
Baillie Gifford Updates Alnylam Pharma Stake (SC 13G/A) — Jan 29, 2024
Baillie Gifford & Co, a prominent investment management firm, filed an amended SC 13G/A on January 29, 2024, indicating a change in their ownership of Alnylam P
BlackRock Amends ALNYLAM PHARMACEUTICALS Stake (SC 13G/A) — Jan 26, 2024
BlackRock Inc. filed an amended SC 13G/A on January 26, 2024, indicating a change in its ownership of ALNYLAM PHARMACEUTICALS, INC. common stock as of December

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX